nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DGUOK—Purine salvage—PNP—osteoporosis	0.0737	0.183	CbGpPWpGaD
Nelarabine—DGUOK—Purine metabolism—ATIC—osteoporosis	0.035	0.087	CbGpPWpGaD
Nelarabine—DGUOK—Purine metabolism—PNP—osteoporosis	0.035	0.087	CbGpPWpGaD
Nelarabine—ADA—Purine salvage—PNP—osteoporosis	0.0245	0.0608	CbGpPWpGaD
Nelarabine—DCK—Purine salvage—PNP—osteoporosis	0.0226	0.0561	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—ATIC—osteoporosis	0.0176	0.0437	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—PNP—osteoporosis	0.0176	0.0437	CbGpPWpGaD
Nelarabine—ADA—Purine metabolism—ATIC—osteoporosis	0.0116	0.0289	CbGpPWpGaD
Nelarabine—ADA—Purine metabolism—PNP—osteoporosis	0.0116	0.0289	CbGpPWpGaD
Nelarabine—DCK—Purine metabolism—ATIC—osteoporosis	0.0107	0.0266	CbGpPWpGaD
Nelarabine—DCK—Purine metabolism—PNP—osteoporosis	0.0107	0.0266	CbGpPWpGaD
Nelarabine—DGUOK—Purine metabolism—GPX1—osteoporosis	0.00991	0.0246	CbGpPWpGaD
Nelarabine—Cladribine—PNP—osteoporosis	0.00856	1	CrCbGaD
Nelarabine—ADA—Nucleotide metabolism—ATIC—osteoporosis	0.00583	0.0145	CbGpPWpGaD
Nelarabine—ADA—Nucleotide metabolism—PNP—osteoporosis	0.00583	0.0145	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—ATIC—osteoporosis	0.00538	0.0134	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—PNP—osteoporosis	0.00538	0.0134	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—ID4—osteoporosis	0.00521	0.013	CbGpPWpGaD
Nelarabine—DGUOK—Nucleotide metabolism—GPX1—osteoporosis	0.00498	0.0124	CbGpPWpGaD
Nelarabine—ADA—Purine metabolism—GPX1—osteoporosis	0.00329	0.00818	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—COL1A2—osteoporosis	0.00304	0.00756	CbGpPWpGaD
Nelarabine—DCK—Purine metabolism—GPX1—osteoporosis	0.00304	0.00755	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—WNT1—osteoporosis	0.00276	0.00686	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—VDR—osteoporosis	0.00266	0.00662	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—VDR—osteoporosis	0.00238	0.00592	CbGpPWpGaD
Nelarabine—DCK—Fulvestrant—Estradiol—osteoporosis	0.00231	0.181	CbGdCrCtD
Nelarabine—POLA1—Norethindrone—Ethinyl Estradiol—osteoporosis	0.00221	0.172	CbGdCrCtD
Nelarabine—DCK—Estradiol valerate/Dienogest—Estradiol—osteoporosis	0.00217	0.169	CbGdCrCtD
Nelarabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—osteoporosis	0.00212	0.165	CbGdCrCtD
Nelarabine—DGUOK—Metabolism—PKM—osteoporosis	0.00184	0.00458	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—FDPS—osteoporosis	0.00184	0.00458	CbGpPWpGaD
Nelarabine—POLA1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00176	0.137	CbGdCrCtD
Nelarabine—DGUOK—Metabolism—GPD2—osteoporosis	0.00175	0.00434	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PGLS—osteoporosis	0.00175	0.00434	CbGpPWpGaD
Nelarabine—ADA—Nucleotide metabolism—GPX1—osteoporosis	0.00165	0.00411	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication Pre-Initiation—PSMA2—osteoporosis	0.00164	0.00408	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication Pre-Initiation—PSMA5—osteoporosis	0.00164	0.00408	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ATIC—osteoporosis	0.0016	0.00397	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PNP—osteoporosis	0.0016	0.00397	CbGpPWpGaD
Nelarabine—DCK—Levorphanol—Estradiol—osteoporosis	0.00153	0.119	CbGdCrCtD
Nelarabine—DCK—Nucleotide metabolism—GPX1—osteoporosis	0.00153	0.00379	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—PSMA2—osteoporosis	0.00143	0.00356	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—PSMA5—osteoporosis	0.00143	0.00356	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—OXCT1—osteoporosis	0.00136	0.00338	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CA2—osteoporosis	0.00136	0.00338	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—PSMA2—osteoporosis	0.00134	0.00334	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—PSMA5—osteoporosis	0.00134	0.00334	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—MGLL—osteoporosis	0.00132	0.00329	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—PSMA2—osteoporosis	0.00129	0.00322	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—PSMA5—osteoporosis	0.00129	0.00322	CbGpPWpGaD
Nelarabine—POLA1—S Phase—PSMA2—osteoporosis	0.00117	0.00292	CbGpPWpGaD
Nelarabine—POLA1—S Phase—PSMA5—osteoporosis	0.00117	0.00292	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—IDH2—osteoporosis	0.00112	0.0028	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.00109	0.00271	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.00109	0.00271	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP27A1—osteoporosis	0.00106	0.00263	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00104	0.00258	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ACP5—osteoporosis	0.00103	0.00256	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—TPI1—osteoporosis	0.000956	0.00238	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—P4HB—osteoporosis	0.000899	0.00224	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GAPDH—osteoporosis	0.000883	0.0022	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—RAP1A—osteoporosis	0.00086	0.00214	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000738	0.00183	CbGpPWpGaD
Nelarabine—DCK—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000724	0.0565	CbGdCrCtD
Nelarabine—ADA—p73 transcription factor network—MYC—osteoporosis	0.000698	0.00174	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ENO1—osteoporosis	0.000695	0.00173	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000685	0.00119	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PSMA2—osteoporosis	0.000685	0.0017	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PSMA5—osteoporosis	0.000685	0.0017	CbGpPWpGaD
Nelarabine—Depression—Estradiol—osteoporosis	0.000684	0.00119	CcSEcCtD
Nelarabine—Fatigue—Ibandronate—osteoporosis	0.000684	0.00119	CcSEcCtD
Nelarabine—Myalgia—Risedronate—osteoporosis	0.000682	0.00118	CcSEcCtD
Nelarabine—Chest pain—Risedronate—osteoporosis	0.000682	0.00118	CcSEcCtD
Nelarabine—Arthralgia—Risedronate—osteoporosis	0.000682	0.00118	CcSEcCtD
Nelarabine—Leukopenia—Pamidronate—osteoporosis	0.000682	0.00118	CcSEcCtD
Nelarabine—Dysgeusia—Zoledronate—osteoporosis	0.000681	0.00118	CcSEcCtD
Nelarabine—Constipation—Ibandronate—osteoporosis	0.000679	0.00118	CcSEcCtD
Nelarabine—Pain—Ibandronate—osteoporosis	0.000679	0.00118	CcSEcCtD
Nelarabine—Gastrointestinal pain—Estropipate—osteoporosis	0.000677	0.00117	CcSEcCtD
Nelarabine—Decreased appetite—Calcitriol—osteoporosis	0.000675	0.00117	CcSEcCtD
Nelarabine—Mental disorder—Conjugated Estrogens—osteoporosis	0.000674	0.00117	CcSEcCtD
Nelarabine—Back pain—Zoledronate—osteoporosis	0.000673	0.00117	CcSEcCtD
Nelarabine—Neuropathy peripheral—Estradiol—osteoporosis	0.000673	0.00117	CcSEcCtD
Nelarabine—Feeling abnormal—Alendronate—osteoporosis	0.000672	0.00116	CcSEcCtD
Nelarabine—Oedema—Ethinyl Estradiol—osteoporosis	0.000671	0.00116	CcSEcCtD
Nelarabine—Malnutrition—Conjugated Estrogens—osteoporosis	0.00067	0.00116	CcSEcCtD
Nelarabine—Loss of consciousness—Pamidronate—osteoporosis	0.000669	0.00116	CcSEcCtD
Nelarabine—Gastrointestinal pain—Alendronate—osteoporosis	0.000666	0.00116	CcSEcCtD
Nelarabine—Infection—Ethinyl Estradiol—osteoporosis	0.000666	0.00116	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—LEP—osteoporosis	0.000666	0.00166	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—MYC—osteoporosis	0.000665	0.00165	CbGpPWpGaD
Nelarabine—Cough—Pamidronate—osteoporosis	0.000665	0.00115	CcSEcCtD
Nelarabine—Pain—Calcitriol—osteoporosis	0.000664	0.00115	CcSEcCtD
Nelarabine—Constipation—Calcitriol—osteoporosis	0.000664	0.00115	CcSEcCtD
Nelarabine—Convulsion—Pamidronate—osteoporosis	0.00066	0.00114	CcSEcCtD
Nelarabine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000658	0.00114	CcSEcCtD
Nelarabine—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000656	0.00114	CcSEcCtD
Nelarabine—Vision blurred—Zoledronate—osteoporosis	0.000656	0.00114	CcSEcCtD
Nelarabine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000655	0.00114	CcSEcCtD
Nelarabine—Diarrhoea—Etidronic acid—osteoporosis	0.000654	0.00114	CcSEcCtD
Nelarabine—Body temperature increased—Estropipate—osteoporosis	0.000654	0.00113	CcSEcCtD
Nelarabine—Abdominal pain—Estropipate—osteoporosis	0.000654	0.00113	CcSEcCtD
Nelarabine—Feeling abnormal—Ibandronate—osteoporosis	0.000654	0.00113	CcSEcCtD
Nelarabine—Tremor—Zoledronate—osteoporosis	0.000652	0.00113	CcSEcCtD
Nelarabine—Infection—Risedronate—osteoporosis	0.00065	0.00113	CcSEcCtD
Nelarabine—Hepatobiliary disease—Estradiol—osteoporosis	0.000649	0.00113	CcSEcCtD
Nelarabine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000649	0.00113	CcSEcCtD
Nelarabine—Myalgia—Pamidronate—osteoporosis	0.000648	0.00112	CcSEcCtD
Nelarabine—Arthralgia—Pamidronate—osteoporosis	0.000648	0.00112	CcSEcCtD
Nelarabine—Back pain—Conjugated Estrogens—osteoporosis	0.000648	0.00112	CcSEcCtD
Nelarabine—Epistaxis—Estradiol—osteoporosis	0.000647	0.00112	CcSEcCtD
Nelarabine—Abdominal pain—Alendronate—osteoporosis	0.000644	0.00112	CcSEcCtD
Nelarabine—Body temperature increased—Alendronate—osteoporosis	0.000644	0.00112	CcSEcCtD
Nelarabine—Sinusitis—Estradiol—osteoporosis	0.000644	0.00112	CcSEcCtD
Nelarabine—Anaemia—Zoledronate—osteoporosis	0.000643	0.00112	CcSEcCtD
Nelarabine—Nervous system disorder—Risedronate—osteoporosis	0.000641	0.00111	CcSEcCtD
Nelarabine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000635	0.0011	CcSEcCtD
Nelarabine—Body temperature increased—Raloxifene—osteoporosis	0.000634	0.0011	CcSEcCtD
Nelarabine—Abdominal pain—Raloxifene—osteoporosis	0.000634	0.0011	CcSEcCtD
Nelarabine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000631	0.0011	CcSEcCtD
Nelarabine—Body temperature increased—Ibandronate—osteoporosis	0.000627	0.00109	CcSEcCtD
Nelarabine—Abdominal pain—Ibandronate—osteoporosis	0.000627	0.00109	CcSEcCtD
Nelarabine—Confusional state—Pamidronate—osteoporosis	0.000627	0.00109	CcSEcCtD
Nelarabine—Leukopenia—Zoledronate—osteoporosis	0.000623	0.00108	CcSEcCtD
Nelarabine—Oedema—Pamidronate—osteoporosis	0.000622	0.00108	CcSEcCtD
Nelarabine—Infection—Pamidronate—osteoporosis	0.000618	0.00107	CcSEcCtD
Nelarabine—Body temperature increased—Calcitriol—osteoporosis	0.000614	0.00107	CcSEcCtD
Nelarabine—Abdominal pain—Calcitriol—osteoporosis	0.000614	0.00107	CcSEcCtD
Nelarabine—Hypoaesthesia—Estradiol—osteoporosis	0.000613	0.00106	CcSEcCtD
Nelarabine—Loss of consciousness—Zoledronate—osteoporosis	0.000612	0.00106	CcSEcCtD
Nelarabine—ADA—Metabolism—FDPS—osteoporosis	0.000611	0.00152	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PKM—osteoporosis	0.000611	0.00152	CbGpPWpGaD
Nelarabine—Nervous system disorder—Pamidronate—osteoporosis	0.00061	0.00106	CcSEcCtD
Nelarabine—Thrombocytopenia—Pamidronate—osteoporosis	0.000609	0.00106	CcSEcCtD
Nelarabine—Urinary tract disorder—Estradiol—osteoporosis	0.000608	0.00106	CcSEcCtD
Nelarabine—Vomiting—Etidronic acid—osteoporosis	0.000608	0.00105	CcSEcCtD
Nelarabine—Cough—Zoledronate—osteoporosis	0.000607	0.00105	CcSEcCtD
Nelarabine—Oedema peripheral—Estradiol—osteoporosis	0.000607	0.00105	CcSEcCtD
Nelarabine—Connective tissue disorder—Estradiol—osteoporosis	0.000605	0.00105	CcSEcCtD
Nelarabine—Urethral disorder—Estradiol—osteoporosis	0.000604	0.00105	CcSEcCtD
Nelarabine—Convulsion—Zoledronate—osteoporosis	0.000603	0.00105	CcSEcCtD
Nelarabine—Headache—Etidronic acid—osteoporosis	0.000599	0.00104	CcSEcCtD
Nelarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000596	0.00148	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000596	0.00103	CcSEcCtD
Nelarabine—Asthenia—Estropipate—osteoporosis	0.000594	0.00103	CcSEcCtD
Nelarabine—Anorexia—Pamidronate—osteoporosis	0.000593	0.00103	CcSEcCtD
Nelarabine—Chest pain—Zoledronate—osteoporosis	0.000592	0.00103	CcSEcCtD
Nelarabine—Myalgia—Zoledronate—osteoporosis	0.000592	0.00103	CcSEcCtD
Nelarabine—Arthralgia—Zoledronate—osteoporosis	0.000592	0.00103	CcSEcCtD
Nelarabine—Insomnia—Risedronate—osteoporosis	0.000591	0.00103	CcSEcCtD
Nelarabine—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000589	0.00102	CcSEcCtD
Nelarabine—Paraesthesia—Risedronate—osteoporosis	0.000587	0.00102	CcSEcCtD
Nelarabine—Asthenia—Alendronate—osteoporosis	0.000585	0.00101	CcSEcCtD
Nelarabine—Cough—Conjugated Estrogens—osteoporosis	0.000585	0.00101	CcSEcCtD
Nelarabine—Dyspnoea—Risedronate—osteoporosis	0.000583	0.00101	CcSEcCtD
Nelarabine—Hypotension—Pamidronate—osteoporosis	0.000581	0.00101	CcSEcCtD
Nelarabine—Convulsion—Conjugated Estrogens—osteoporosis	0.00058	0.00101	CcSEcCtD
Nelarabine—ADA—Metabolism—GPD2—osteoporosis	0.000579	0.00144	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PGLS—osteoporosis	0.000579	0.00144	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000579	0.001	CcSEcCtD
Nelarabine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000578	0.001	CcSEcCtD
Nelarabine—Eye disorder—Estradiol—osteoporosis	0.000576	0.000998	CcSEcCtD
Nelarabine—Constipation—Ethinyl Estradiol—osteoporosis	0.000574	0.000995	CcSEcCtD
Nelarabine—Confusional state—Zoledronate—osteoporosis	0.000573	0.000993	CcSEcCtD
Nelarabine—Cardiac disorder—Estradiol—osteoporosis	0.000572	0.000992	CcSEcCtD
Nelarabine—Chest pain—Conjugated Estrogens—osteoporosis	0.00057	0.000989	CcSEcCtD
Nelarabine—Myalgia—Conjugated Estrogens—osteoporosis	0.00057	0.000989	CcSEcCtD
Nelarabine—Arthralgia—Conjugated Estrogens—osteoporosis	0.00057	0.000989	CcSEcCtD
Nelarabine—Asthenia—Ibandronate—osteoporosis	0.000569	0.000988	CcSEcCtD
Nelarabine—Nausea—Etidronic acid—osteoporosis	0.000568	0.000986	CcSEcCtD
Nelarabine—Oedema—Zoledronate—osteoporosis	0.000568	0.000985	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000566	0.000982	CcSEcCtD
Nelarabine—Diarrhoea—Estropipate—osteoporosis	0.000566	0.000982	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000565	0.000979	CcSEcCtD
Nelarabine—DCK—Metabolism—FDPS—osteoporosis	0.000564	0.0014	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PKM—osteoporosis	0.000564	0.0014	CbGpPWpGaD
Nelarabine—Infection—Zoledronate—osteoporosis	0.000564	0.000979	CcSEcCtD
Nelarabine—Fatigue—Risedronate—osteoporosis	0.000564	0.000978	CcSEcCtD
Nelarabine—Insomnia—Pamidronate—osteoporosis	0.000562	0.000975	CcSEcCtD
Nelarabine—Constipation—Risedronate—osteoporosis	0.000559	0.00097	CcSEcCtD
Nelarabine—Pain—Risedronate—osteoporosis	0.000559	0.00097	CcSEcCtD
Nelarabine—Angiopathy—Estradiol—osteoporosis	0.000559	0.000969	CcSEcCtD
Nelarabine—Paraesthesia—Pamidronate—osteoporosis	0.000558	0.000968	CcSEcCtD
Nelarabine—Diarrhoea—Alendronate—osteoporosis	0.000558	0.000967	CcSEcCtD
Nelarabine—Asthenia—Calcitriol—osteoporosis	0.000557	0.000967	CcSEcCtD
Nelarabine—Nervous system disorder—Zoledronate—osteoporosis	0.000557	0.000966	CcSEcCtD
Nelarabine—Thrombocytopenia—Zoledronate—osteoporosis	0.000556	0.000964	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CYP19A1—osteoporosis	0.000556	0.00138	CbGpPWpGaD
Nelarabine—Mediastinal disorder—Estradiol—osteoporosis	0.000555	0.000963	CcSEcCtD
Nelarabine—Dyspnoea—Pamidronate—osteoporosis	0.000554	0.000961	CcSEcCtD
Nelarabine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000553	0.000959	CcSEcCtD
Nelarabine—Chills—Estradiol—osteoporosis	0.000553	0.000959	CcSEcCtD
Nelarabine—Somnolence—Pamidronate—osteoporosis	0.000553	0.000959	CcSEcCtD
Nelarabine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000548	0.000951	CcSEcCtD
Nelarabine—Diarrhoea—Raloxifene—osteoporosis	0.000548	0.000951	CcSEcCtD
Nelarabine—Dizziness—Estropipate—osteoporosis	0.000547	0.000949	CcSEcCtD
Nelarabine—Oedema—Conjugated Estrogens—osteoporosis	0.000547	0.000948	CcSEcCtD
Nelarabine—Infection—Conjugated Estrogens—osteoporosis	0.000543	0.000942	CcSEcCtD
Nelarabine—Diarrhoea—Ibandronate—osteoporosis	0.000543	0.000942	CcSEcCtD
Nelarabine—Anorexia—Zoledronate—osteoporosis	0.000541	0.000939	CcSEcCtD
Nelarabine—Decreased appetite—Pamidronate—osteoporosis	0.00054	0.000937	CcSEcCtD
Nelarabine—Mental disorder—Estradiol—osteoporosis	0.00054	0.000936	CcSEcCtD
Nelarabine—Dizziness—Alendronate—osteoporosis	0.000539	0.000935	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000537	0.000931	CcSEcCtD
Nelarabine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000536	0.00093	CcSEcCtD
Nelarabine—Malnutrition—Estradiol—osteoporosis	0.000536	0.00093	CcSEcCtD
Nelarabine—Fatigue—Pamidronate—osteoporosis	0.000536	0.00093	CcSEcCtD
Nelarabine—DCK—Metabolism—PGLS—osteoporosis	0.000535	0.00133	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPD2—osteoporosis	0.000535	0.00133	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Risedronate—osteoporosis	0.000535	0.000928	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PSMA5—osteoporosis	0.000534	0.00133	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PSMA2—osteoporosis	0.000534	0.00133	CbGpPWpGaD
Nelarabine—Constipation—Pamidronate—osteoporosis	0.000532	0.000922	CcSEcCtD
Nelarabine—Pain—Pamidronate—osteoporosis	0.000532	0.000922	CcSEcCtD
Nelarabine—Diarrhoea—Calcitriol—osteoporosis	0.000531	0.000922	CcSEcCtD
Nelarabine—Hypotension—Zoledronate—osteoporosis	0.000531	0.00092	CcSEcCtD
Nelarabine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00053	0.00092	CcSEcCtD
Nelarabine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00053	0.00092	CcSEcCtD
Nelarabine—Dizziness—Raloxifene—osteoporosis	0.00053	0.000919	CcSEcCtD
Nelarabine—ADA—Metabolism—PNP—osteoporosis	0.00053	0.00132	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ATIC—osteoporosis	0.00053	0.00132	CbGpPWpGaD
Nelarabine—Vomiting—Estropipate—osteoporosis	0.000526	0.000913	CcSEcCtD
Nelarabine—Dysgeusia—Estradiol—osteoporosis	0.000525	0.000911	CcSEcCtD
Nelarabine—Dizziness—Ibandronate—osteoporosis	0.000525	0.00091	CcSEcCtD
Nelarabine—Anorexia—Conjugated Estrogens—osteoporosis	0.000521	0.000904	CcSEcCtD
Nelarabine—Back pain—Estradiol—osteoporosis	0.000519	0.0009	CcSEcCtD
Nelarabine—Headache—Estropipate—osteoporosis	0.000518	0.000899	CcSEcCtD
Nelarabine—Vomiting—Alendronate—osteoporosis	0.000518	0.000899	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000517	0.000897	CcSEcCtD
Nelarabine—Abdominal pain—Risedronate—osteoporosis	0.000517	0.000897	CcSEcCtD
Nelarabine—Body temperature increased—Risedronate—osteoporosis	0.000517	0.000897	CcSEcCtD
Nelarabine—Insomnia—Zoledronate—osteoporosis	0.000514	0.000891	CcSEcCtD
Nelarabine—Feeling abnormal—Pamidronate—osteoporosis	0.000512	0.000889	CcSEcCtD
Nelarabine—Hypotension—Conjugated Estrogens—osteoporosis	0.000511	0.000886	CcSEcCtD
Nelarabine—Headache—Alendronate—osteoporosis	0.000511	0.000886	CcSEcCtD
Nelarabine—Paraesthesia—Zoledronate—osteoporosis	0.00051	0.000884	CcSEcCtD
Nelarabine—Vomiting—Raloxifene—osteoporosis	0.00051	0.000884	CcSEcCtD
Nelarabine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000508	0.000882	CcSEcCtD
Nelarabine—Dyspnoea—Zoledronate—osteoporosis	0.000506	0.000878	CcSEcCtD
Nelarabine—Somnolence—Zoledronate—osteoporosis	0.000505	0.000876	CcSEcCtD
Nelarabine—Vomiting—Ibandronate—osteoporosis	0.000505	0.000875	CcSEcCtD
Nelarabine—POLA1—E2F transcription factor network—MYC—osteoporosis	0.000502	0.00125	CbGpPWpGaD
Nelarabine—Tremor—Estradiol—osteoporosis	0.000502	0.000871	CcSEcCtD
Nelarabine—Headache—Raloxifene—osteoporosis	0.000502	0.000871	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000498	0.000864	CcSEcCtD
Nelarabine—Headache—Ibandronate—osteoporosis	0.000497	0.000862	CcSEcCtD
Nelarabine—Insomnia—Conjugated Estrogens—osteoporosis	0.000495	0.000858	CcSEcCtD
Nelarabine—Vomiting—Calcitriol—osteoporosis	0.000494	0.000857	CcSEcCtD
Nelarabine—Decreased appetite—Zoledronate—osteoporosis	0.000494	0.000856	CcSEcCtD
Nelarabine—Nausea—Estropipate—osteoporosis	0.000492	0.000853	CcSEcCtD
Nelarabine—Abdominal pain—Pamidronate—osteoporosis	0.000491	0.000852	CcSEcCtD
Nelarabine—Body temperature increased—Pamidronate—osteoporosis	0.000491	0.000852	CcSEcCtD
Nelarabine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000491	0.000852	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00049	0.00085	CcSEcCtD
Nelarabine—Fatigue—Zoledronate—osteoporosis	0.00049	0.000849	CcSEcCtD
Nelarabine—DCK—Metabolism—ATIC—osteoporosis	0.000489	0.00122	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PNP—osteoporosis	0.000489	0.00122	CbGpPWpGaD
Nelarabine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000487	0.000846	CcSEcCtD
Nelarabine—Headache—Calcitriol—osteoporosis	0.000487	0.000844	CcSEcCtD
Nelarabine—Somnolence—Conjugated Estrogens—osteoporosis	0.000486	0.000843	CcSEcCtD
Nelarabine—Constipation—Zoledronate—osteoporosis	0.000486	0.000842	CcSEcCtD
Nelarabine—Pain—Zoledronate—osteoporosis	0.000486	0.000842	CcSEcCtD
Nelarabine—Nausea—Alendronate—osteoporosis	0.000484	0.00084	CcSEcCtD
Nelarabine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000481	0.000835	CcSEcCtD
Nelarabine—Nausea—Raloxifene—osteoporosis	0.000476	0.000826	CcSEcCtD
Nelarabine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000475	0.000824	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000472	0.000819	CcSEcCtD
Nelarabine—Fatigue—Conjugated Estrogens—osteoporosis	0.000471	0.000818	CcSEcCtD
Nelarabine—Nausea—Ibandronate—osteoporosis	0.000471	0.000818	CcSEcCtD
Nelarabine—Loss of consciousness—Estradiol—osteoporosis	0.000471	0.000817	CcSEcCtD
Nelarabine—Asthenia—Risedronate—osteoporosis	0.000469	0.000814	CcSEcCtD
Nelarabine—Feeling abnormal—Zoledronate—osteoporosis	0.000468	0.000812	CcSEcCtD
Nelarabine—Cough—Estradiol—osteoporosis	0.000468	0.000812	CcSEcCtD
Nelarabine—Constipation—Conjugated Estrogens—osteoporosis	0.000468	0.000811	CcSEcCtD
Nelarabine—Pain—Conjugated Estrogens—osteoporosis	0.000468	0.000811	CcSEcCtD
Nelarabine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000464	0.000805	CcSEcCtD
Nelarabine—Nausea—Calcitriol—osteoporosis	0.000461	0.0008	CcSEcCtD
Nelarabine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000459	0.000796	CcSEcCtD
Nelarabine—Myalgia—Estradiol—osteoporosis	0.000456	0.000792	CcSEcCtD
Nelarabine—Chest pain—Estradiol—osteoporosis	0.000456	0.000792	CcSEcCtD
Nelarabine—Arthralgia—Estradiol—osteoporosis	0.000456	0.000792	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ADCY5—osteoporosis	0.000454	0.00113	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GPX1—osteoporosis	0.000452	0.00113	CbGpPWpGaD
Nelarabine—ADA—Metabolism—OXCT1—osteoporosis	0.000451	0.00112	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CA2—osteoporosis	0.000451	0.00112	CbGpPWpGaD
Nelarabine—Abdominal pain—Zoledronate—osteoporosis	0.000449	0.000779	CcSEcCtD
Nelarabine—Body temperature increased—Zoledronate—osteoporosis	0.000449	0.000779	CcSEcCtD
Nelarabine—Diarrhoea—Risedronate—osteoporosis	0.000447	0.000776	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000447	0.00111	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000447	0.000776	CcSEcCtD
Nelarabine—Asthenia—Pamidronate—osteoporosis	0.000446	0.000774	CcSEcCtD
Nelarabine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000444	0.000769	CcSEcCtD
Nelarabine—Confusional state—Estradiol—osteoporosis	0.000441	0.000765	CcSEcCtD
Nelarabine—ADA—Metabolism—MGLL—osteoporosis	0.000439	0.00109	CbGpPWpGaD
Nelarabine—Oedema—Estradiol—osteoporosis	0.000438	0.000759	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000437	0.00109	CbGpPWpGaD
Nelarabine—Infection—Estradiol—osteoporosis	0.000435	0.000754	CcSEcCtD
Nelarabine—Dizziness—Risedronate—osteoporosis	0.000432	0.00075	CcSEcCtD
Nelarabine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000432	0.00075	CcSEcCtD
Nelarabine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000432	0.00075	CcSEcCtD
Nelarabine—Nervous system disorder—Estradiol—osteoporosis	0.000429	0.000744	CcSEcCtD
Nelarabine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000426	0.00074	CcSEcCtD
Nelarabine—Diarrhoea—Pamidronate—osteoporosis	0.000425	0.000738	CcSEcCtD
Nelarabine—Headache—Ethinyl Estradiol—osteoporosis	0.00042	0.000729	CcSEcCtD
Nelarabine—DGUOK—Metabolism—MTHFR—osteoporosis	0.000417	0.00104	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CA2—osteoporosis	0.000416	0.00103	CbGpPWpGaD
Nelarabine—DCK—Metabolism—OXCT1—osteoporosis	0.000416	0.00103	CbGpPWpGaD
Nelarabine—Vomiting—Risedronate—osteoporosis	0.000416	0.000721	CcSEcCtD
Nelarabine—Dizziness—Pamidronate—osteoporosis	0.000411	0.000713	CcSEcCtD
Nelarabine—Headache—Risedronate—osteoporosis	0.00041	0.000711	CcSEcCtD
Nelarabine—Asthenia—Zoledronate—osteoporosis	0.000407	0.000707	CcSEcCtD
Nelarabine—DCK—Metabolism—MGLL—osteoporosis	0.000405	0.00101	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.0004	0.000994	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.0004	0.000994	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000399	0.000692	CcSEcCtD
Nelarabine—Nausea—Ethinyl Estradiol—osteoporosis	0.000398	0.000691	CcSEcCtD
Nelarabine—Insomnia—Estradiol—osteoporosis	0.000396	0.000687	CcSEcCtD
Nelarabine—Vomiting—Pamidronate—osteoporosis	0.000395	0.000686	CcSEcCtD
Nelarabine—Paraesthesia—Estradiol—osteoporosis	0.000393	0.000682	CcSEcCtD
Nelarabine—Asthenia—Conjugated Estrogens—osteoporosis	0.000392	0.00068	CcSEcCtD
Nelarabine—Dyspnoea—Estradiol—osteoporosis	0.00039	0.000677	CcSEcCtD
Nelarabine—Headache—Pamidronate—osteoporosis	0.000389	0.000676	CcSEcCtD
Nelarabine—Somnolence—Estradiol—osteoporosis	0.000389	0.000675	CcSEcCtD
Nelarabine—Diarrhoea—Zoledronate—osteoporosis	0.000389	0.000674	CcSEcCtD
Nelarabine—Nausea—Risedronate—osteoporosis	0.000388	0.000674	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000387	0.000963	CbGpPWpGaD
Nelarabine—Decreased appetite—Estradiol—osteoporosis	0.00038	0.00066	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000378	0.000655	CcSEcCtD
Nelarabine—Fatigue—Estradiol—osteoporosis	0.000377	0.000654	CcSEcCtD
Nelarabine—Dizziness—Zoledronate—osteoporosis	0.000376	0.000651	CcSEcCtD
Nelarabine—Constipation—Estradiol—osteoporosis	0.000374	0.000649	CcSEcCtD
Nelarabine—Pain—Estradiol—osteoporosis	0.000374	0.000649	CcSEcCtD
Nelarabine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000374	0.000649	CcSEcCtD
Nelarabine—ADA—Metabolism—IDH2—osteoporosis	0.000373	0.000929	CbGpPWpGaD
Nelarabine—Nausea—Pamidronate—osteoporosis	0.000369	0.000641	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—MYC—osteoporosis	0.000365	0.000907	CbGpPWpGaD
Nelarabine—Dizziness—Conjugated Estrogens—osteoporosis	0.000362	0.000627	CcSEcCtD
Nelarabine—Vomiting—Zoledronate—osteoporosis	0.000361	0.000626	CcSEcCtD
Nelarabine—Feeling abnormal—Estradiol—osteoporosis	0.000361	0.000626	CcSEcCtD
Nelarabine—Gastrointestinal pain—Estradiol—osteoporosis	0.000358	0.000621	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—PSMA5—osteoporosis	0.000357	0.000889	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PSMA2—osteoporosis	0.000357	0.000889	CbGpPWpGaD
Nelarabine—Headache—Zoledronate—osteoporosis	0.000356	0.000617	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP27A1—osteoporosis	0.000351	0.000873	CbGpPWpGaD
Nelarabine—Vomiting—Conjugated Estrogens—osteoporosis	0.000348	0.000603	CcSEcCtD
Nelarabine—Body temperature increased—Estradiol—osteoporosis	0.000346	0.0006	CcSEcCtD
Nelarabine—Abdominal pain—Estradiol—osteoporosis	0.000346	0.0006	CcSEcCtD
Nelarabine—DCK—Metabolism—IDH2—osteoporosis	0.000345	0.000857	CbGpPWpGaD
Nelarabine—Headache—Conjugated Estrogens—osteoporosis	0.000343	0.000594	CcSEcCtD
Nelarabine—ADA—Metabolism—ACP5—osteoporosis	0.000342	0.000849	CbGpPWpGaD
Nelarabine—Nausea—Zoledronate—osteoporosis	0.000337	0.000585	CcSEcCtD
Nelarabine—DGUOK—Metabolism—POMC—osteoporosis	0.000334	0.00083	CbGpPWpGaD
Nelarabine—POLA1—S Phase—MYC—osteoporosis	0.000331	0.000823	CbGpPWpGaD
Nelarabine—Nausea—Conjugated Estrogens—osteoporosis	0.000325	0.000563	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP27A1—osteoporosis	0.000324	0.000806	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TPI1—osteoporosis	0.000318	0.00079	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ACP5—osteoporosis	0.000315	0.000784	CbGpPWpGaD
Nelarabine—Asthenia—Estradiol—osteoporosis	0.000314	0.000545	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000307	0.000764	CbGpPWpGaD
Nelarabine—Diarrhoea—Estradiol—osteoporosis	0.000299	0.000519	CcSEcCtD
Nelarabine—ADA—Metabolism—P4HB—osteoporosis	0.000299	0.000742	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TPI1—osteoporosis	0.000293	0.000729	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GAPDH—osteoporosis	0.000293	0.000729	CbGpPWpGaD
Nelarabine—Dizziness—Estradiol—osteoporosis	0.000289	0.000502	CcSEcCtD
Nelarabine—ADA—Metabolism—RAP1A—osteoporosis	0.000285	0.00071	CbGpPWpGaD
Nelarabine—Vomiting—Estradiol—osteoporosis	0.000278	0.000483	CcSEcCtD
Nelarabine—DCK—Metabolism—P4HB—osteoporosis	0.000276	0.000685	CbGpPWpGaD
Nelarabine—Headache—Estradiol—osteoporosis	0.000274	0.000476	CcSEcCtD
Nelarabine—DCK—Metabolism—GAPDH—osteoporosis	0.00027	0.000673	CbGpPWpGaD
Nelarabine—DCK—Metabolism—RAP1A—osteoporosis	0.000263	0.000655	CbGpPWpGaD
Nelarabine—Nausea—Estradiol—osteoporosis	0.00026	0.000451	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—IL6—osteoporosis	0.000249	0.000618	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000233	0.000579	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000232	0.000577	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ENO1—osteoporosis	0.000231	0.000574	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PSMA5—osteoporosis	0.000227	0.000565	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PSMA2—osteoporosis	0.000227	0.000565	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000217	0.000539	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ENO1—osteoporosis	0.000213	0.000529	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PSMA2—osteoporosis	0.00021	0.000522	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PSMA5—osteoporosis	0.00021	0.000522	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP19A1—osteoporosis	0.000184	0.000459	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP19A1—osteoporosis	0.00017	0.000423	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ADCY5—osteoporosis	0.000151	0.000375	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPX1—osteoporosis	0.00015	0.000373	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ADCY5—osteoporosis	0.000139	0.000346	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTHFR—osteoporosis	0.000139	0.000345	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPX1—osteoporosis	0.000139	0.000345	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTHFR—osteoporosis	0.000128	0.000318	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—osteoporosis	0.000113	0.00028	CbGpPWpGaD
Nelarabine—ADA—Metabolism—POMC—osteoporosis	0.000111	0.000276	CbGpPWpGaD
Nelarabine—DCK—Metabolism—POMC—osteoporosis	0.000102	0.000254	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—osteoporosis	0.000101	0.000251	CbGpPWpGaD
